Moderna, Inc. (MRNA) Social Stream



Moderna, Inc. (MRNA): $142.19

-3.17 (-2.18%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MRNA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 398

in industry

Moderna Inc (MRNA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Moderna Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 15 $475 $86 $245.923 $172.54 42.53%
2021-11-26 14 $475 $86 $257.333 $172.54 49.14%
2021-12-10 14 $475 $86 $256.769 $172.54 48.82%
2021-12-20 13 $475 $86 $256.769 $172.54 48.82%
2022-01-03 13 $475 $86 $254.846 $172.54 47.7%
2022-01-10 13 $506 $86 $257.23 $172.54 49.08%
2022-01-18 13 $506 $86 $257.384 $172.54 49.17%
2022-01-21 14 $506 $86 $250.857 $172.54 45.39%
2022-01-27 14 $506 $86 $249.071 $172.54 44.36%
2022-01-31 14 $506 $85 $245.428 $172.54 42.24%
2022-02-22 14 $506 $85 $245.307 $172.54 42.17%
2022-02-25 14 $506 $85 $244.538 $172.54 41.73%
2022-03-18 14 $506 $81 $240.384 $172.54 39.32%
2022-03-25 14 $506 $81 $241.153 $172.54 39.77%
2022-04-01 14 $506 $80 $241.077 $172.54 39.72%

The Trend in the Analyst Price Target


Over the past 37 weeks, MRNA's average price target has gone up $50.22.

MRNA reports an average of 18.56% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-13 16 246 83 181.170 218.85 -17.22%
2022-01-10 13 506 86 257.230 233.70 10.07%
2022-02-21 14 506 85 245.307 145.74 68.32%
2022-03-17 14 506 81 240.384 168.26 42.86%
2022-03-30 14 506 80 241.077 174.92 37.82%

MRNA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.43 5 0 8 1 1 14

The Trend in the Broker Recommendations


Over the past 26 weeks, MRNA's average broker recommendation rating improved by 0.33.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MRNA as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, Moderna Inc's variance in analysts' estimates is lower than -1771.59% of them.
  • In the context of Pharmaceutical Products stocks, Moderna Inc's average analyst price target is greater than 1827.33% of them.
  • In the context of Pharmaceutical Products stocks, Moderna Inc's number of analysts covering the stock is greater than 1714.12% of them.
  • In terms of how Moderna Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 400.02% of that group.

Stocks similar to Moderna Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are GILD, DNLI, and DNA.

Is MRNA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.595 seconds.